相关实验视频
Updated: Jan 15, 2026

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
1.6K
在创伤引起的休克后,ADAMTS13在高纤维素解中的新型作用☆
Pieter H Sloos1, Lisa Vermeersch2, Daphne S Roozendaal3
1Department of Intensive Care Medicine, location University of Amsterdam, Amsterdam, The Netherlands; Laboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
British journal of anaesthesia
|October 8, 2025
概括
创伤患者的过敏纤维素溶解表现出ADAMTS13的过活形式 (一种具有血栓素1型动机的分解蛋白和金属蛋白酶13),增加了死亡率. 特兰胺酸防止ADAMTS13的降解,提供了一个潜在的治疗点.
科学领域:
- 血液学 血液学 血液学
- 创伤医学 创伤医学
- 生物化学 生物化学
背景情况:
- 创伤诱导的凝血病和纤维纤维溶解与高死亡率有关.
- 蛋白质酶ADAMTS13 (一种具有血栓素1型基因的分解蛋白和金属蛋白酶13) 在组织受伤后发生裂变.
- 了解ADAMTS13裂变机制对于解决创伤诱导的过纤维素分解至关重要.
研究的目的:
- 研究创伤后ADAMTS13蛋白质分解裂变背后的机制.
- 确定ADAMTS13构造对创伤诱导的纤维纤维解和患者结局的影响.
- 探索特兰胺酸在防止ADAMTS13降解方面的潜力.
主要方法:
- 基于ADAMTS13形态的39名创伤患者在休克中的分层.
- 在体外分析ADAMTS13裂变机制,使用来自健康志愿者的血液.
- 评估ADAMTS13在高纤维素溶解中的作用,使用旋转血栓形成显微镜 (ROTEM) 和纤维素形成试验.
主要成果:
- 在23%的创伤患者中观察到一个截断的,过度活跃的ADAMTS13形状,与增加的超纤维素解和死亡率相关.
- 实验室研究表明,组织等离子体激活剂和等离子体分裂ADAMTS13,增强其活性.
- 特兰胺酸有效地抑制了ADAMTS13的裂变和激活,而过度激活的ADAMTS13则直接促进了过纤维素分解.
结论:
- 创伤性休克可能导致截断,过度激活的ADAMTS13,显著与过纤维素分解和死亡率增加有关.
- 组织等离子素激活剂和等离子素是ADAMTS13过激活的关键诱导剂.
- ADAMTS13直接对高纤维素分解作出贡献,而特兰胺酸显示出防止其有害激活的潜力.
相关概念视频
Clot Retraction and Fibrinolysis
8.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.4K
Extrinsic and Intrinsic Pathways of Hemostasis
12.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.1K
Formation of the Platelet Plug
8.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.7K
Introduction to Hemostasis
13.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.3K
Coagulation
9.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K

